Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • New Therapeutic Targets in Cardiovascular Diseases (Upcoming)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI106759

Effects of cardiac depression and of anesthesia on the myocardial action of a cardiac glycoside

Stephen F. Vatner, Charles B. Higgins, Thomas Patrick, Dean Franklin, and Eugene Braunwald

Department of Medicine, University of California, San Diego, California 92037

School of Medicine and Scripps Clinic and Research Foundation, La Jolla, California 92037

Find articles by Vatner, S. in: JCI | PubMed | Google Scholar

Department of Medicine, University of California, San Diego, California 92037

School of Medicine and Scripps Clinic and Research Foundation, La Jolla, California 92037

Find articles by Higgins, C. in: JCI | PubMed | Google Scholar

Department of Medicine, University of California, San Diego, California 92037

School of Medicine and Scripps Clinic and Research Foundation, La Jolla, California 92037

Find articles by Patrick, T. in: JCI | PubMed | Google Scholar

Department of Medicine, University of California, San Diego, California 92037

School of Medicine and Scripps Clinic and Research Foundation, La Jolla, California 92037

Find articles by Franklin, D. in: JCI | PubMed | Google Scholar

Department of Medicine, University of California, San Diego, California 92037

School of Medicine and Scripps Clinic and Research Foundation, La Jolla, California 92037

Find articles by Braunwald, E. in: JCI | PubMed | Google Scholar

Published December 1, 1971 - More info

Published in Volume 50, Issue 12 on December 1, 1971
J Clin Invest. 1971;50(12):2585–2595. https://doi.org/10.1172/JCI106759.
© 1971 The American Society for Clinical Investigation
Published December 1, 1971 - Version history
View PDF
Abstract

The effects of ouabain (G-strophanthin) 20 μg/kg, on left ventricular (LV) pressure (P), diameter (D), velocity of contraction (dD/dt), and dP/dt were studied in conscious dogs instrumented with ultrasonic diameter gauges and miniature pressure gauges. The effects of ouabain were compared on separate occasions in the same dogs after cardiac depression with propranolol, 3.0 mg/kg, and also after general anesthesia with Na pentobarbital, 30 mg/kg. Maximal pressor effects were observed in the first 10 min, but maximal effects on the contractile state occurred at 30 min after ouabain. At this time, in conscious dogs, ouabain had increased LV isolength systolic pressure by 5%, LV isolength velocity by only 9%, and LV (dP/dt)/P by 21%, while end systolic diameter (ESD) decreased slightly and end diastolic diameter (EDD) and heart rate (HR) were unchanged. After anesthesia, ouabain increased LV systolic pressure by 8%, velocity 32%, (dP/dt)/P by 47%, and ESD decreased by 1.2 mm while EDD rose slightly and HR fell by 26 beats/min. Returning HR to control with atrial pacing decreased EDD 0.9 mm below control. After cardiac depression with propranolol, ouabain caused responses similar to those observed in the anesthetized dogs. Thus, the cardiac glycoside was found to exert only minor inotropic effects on the nonfailing heart of conscious dogs but far more striking inotropic responses in the anesthetized state.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2585
page 2585
icon of scanned page 2586
page 2586
icon of scanned page 2587
page 2587
icon of scanned page 2588
page 2588
icon of scanned page 2589
page 2589
icon of scanned page 2590
page 2590
icon of scanned page 2591
page 2591
icon of scanned page 2592
page 2592
icon of scanned page 2593
page 2593
icon of scanned page 2594
page 2594
icon of scanned page 2595
page 2595
Version history
  • Version 1 (December 1, 1971): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts